Market Place
Sourcing Support
All News #Library
Biotech
Kodiak Sciences Announces Positive Topline Results in GLOW2
26 Mar 2026 //
PR NEWSWIRE
Kodiak Presents KSI-101 Data in Macular Edema at Angiogenesis
04 Feb 2026 //
PR NEWSWIRE
Kodiak Sciences Closes $184M Offering with Full Option Exercise
18 Dec 2025 //
PR NEWSWIRE
Kodiak Sciences To Present At Upcoming Investor Conferences
12 Nov 2025 //
PR NEWSWIRE
Kodiak KSI-101 APEX Follow-Up Shows Strong Effect Through Week 20
05 Nov 2025 //
PR NEWSWIRE
Kodiak`s KSI-101 Show Vision Gains, Rapid Retinal Drying in Study
15 Sep 2025 //
PR NEWSWIRE
Kodiak Sciences Showcases KSI-101 at Scientific Conferences
02 Sep 2025 //
PR NEWSWIRE
Kodiak Sciences to Attend American Chemical Society Fall 2025
19 Aug 2025 //
PR NEWSWIRE
Kodiak Sciences to Host Investor R&D Day on July 16, 2025
11 Jul 2025 //
PR NEWSWIRE
Kodiak Sciences Announces Q1 2025 Financial Results
14 May 2025 //
PR NEWSWIRE
Kodiak Sciences Finishes Enrollment in Tarcocimab Trial
10 Mar 2025 //
PR NEWSWIRE
Nona Biosciences and Kodiak Partner on Antibody Therapies
09 Dec 2024 //
PR NEWSWIRE
Kodiak Announces Presentation of First Time Results of KSI-501ABC Phase 1 Study
30 Jan 2024 //
PR NEWSWIRE
Kodiak reboots tarcocimab tedromer development program
06 Nov 2023 //
PR NEWSWIRE
Kodiak Announces First Time Presentation Of Data From Tarcocimab Tedromer
01 Nov 2023 //
PR NEWSWIRE
Kodiak Expands Development Pipeline in Phase 1 Clinical Study of KSI-501
03 Apr 2023 //
PR NEWSWIRE
Kodiak, Lonza Sign Long-Term Manufacturing Contract
27 Jul 2020 //
PRESS RELEASE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.